Any chance Carter is preparing us all for a bombshell announcement on Anagrelide? I mean he has provided two “program updates” within a month of each other, where he basically educates us about what it is, how it can be used for and its all round potential - which is great and all...but nothing given on how they intend to monetise it and it’s possible value?
Why bother with the “program updates” if your not planning anything big with it? Just to look busy or is there actually something material in this?
SUD Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
